rs2228529

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000124.4(ERCC6):​c.4238A>G​(p.Gln1413Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.208 in 1,614,064 control chromosomes in the GnomAD database, including 37,755 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q1413Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.19 ( 3281 hom., cov: 32)
Exomes 𝑓: 0.21 ( 34474 hom. )

Consequence

ERCC6
NM_000124.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.104

Publications

57 publications found
Variant links:
Genes affected
ERCC6 (HGNC:3438): (ERCC excision repair 6, chromatin remodeling factor) This gene encodes a DNA-binding protein that is important in transcription-coupled excision repair. The encoded protein has ATP-stimulated ATPase activity, interacts with several transcription and excision repair proteins, and may promote complex formation at DNA repair sites. Mutations in this gene are associated with Cockayne syndrome type B and cerebrooculofacioskeletal syndrome 1. Alternative splicing occurs between a splice site from exon 5 of this gene to the 3' splice site upstream of the open reading frame (ORF) of the adjacent gene, piggyback-derived-3 (GeneID:267004), which activates the alternative polyadenylation site downstream of the piggyback-derived-3 ORF. The resulting transcripts encode a fusion protein that shares sequence with the product of each individual gene. [provided by RefSeq, Mar 2016]
ERCC6 Gene-Disease associations (from GenCC):
  • Cockayne spectrum with or without cerebrooculofacioskeletal syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Cockayne syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Orphanet, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • UV-sensitive syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • COFS syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • UV-sensitive syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • premature ovarian failure 11
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003504604).
BP6
Variant 10-49459059-T-C is Benign according to our data. Variant chr10-49459059-T-C is described in ClinVar as Benign. ClinVar VariationId is 129020.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.333 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERCC6NM_000124.4 linkc.4238A>G p.Gln1413Arg missense_variant Exon 21 of 21 ENST00000355832.10 NP_000115.1 Q03468-1Q59FF6
ERCC6NM_001346440.2 linkc.4238A>G p.Gln1413Arg missense_variant Exon 21 of 21 NP_001333369.1 Q03468-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERCC6ENST00000355832.10 linkc.4238A>G p.Gln1413Arg missense_variant Exon 21 of 21 1 NM_000124.4 ENSP00000348089.5 Q03468-1

Frequencies

GnomAD3 genomes
AF:
0.194
AC:
29433
AN:
152058
Hom.:
3277
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.123
Gnomad AMI
AF:
0.103
Gnomad AMR
AF:
0.207
Gnomad ASJ
AF:
0.274
Gnomad EAS
AF:
0.0516
Gnomad SAS
AF:
0.346
Gnomad FIN
AF:
0.283
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.216
Gnomad OTH
AF:
0.213
GnomAD2 exomes
AF:
0.217
AC:
54373
AN:
251060
AF XY:
0.228
show subpopulations
Gnomad AFR exome
AF:
0.124
Gnomad AMR exome
AF:
0.171
Gnomad ASJ exome
AF:
0.259
Gnomad EAS exome
AF:
0.0523
Gnomad FIN exome
AF:
0.275
Gnomad NFE exome
AF:
0.219
Gnomad OTH exome
AF:
0.231
GnomAD4 exome
AF:
0.210
AC:
306607
AN:
1461890
Hom.:
34474
Cov.:
34
AF XY:
0.215
AC XY:
156589
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.119
AC:
3993
AN:
33480
American (AMR)
AF:
0.176
AC:
7853
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.261
AC:
6826
AN:
26136
East Asian (EAS)
AF:
0.0533
AC:
2116
AN:
39700
South Asian (SAS)
AF:
0.346
AC:
29815
AN:
86258
European-Finnish (FIN)
AF:
0.268
AC:
14317
AN:
53420
Middle Eastern (MID)
AF:
0.263
AC:
1517
AN:
5768
European-Non Finnish (NFE)
AF:
0.205
AC:
227612
AN:
1112008
Other (OTH)
AF:
0.208
AC:
12558
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
16838
33676
50513
67351
84189
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7680
15360
23040
30720
38400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.193
AC:
29445
AN:
152174
Hom.:
3281
Cov.:
32
AF XY:
0.201
AC XY:
14952
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.123
AC:
5103
AN:
41536
American (AMR)
AF:
0.208
AC:
3178
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.274
AC:
951
AN:
3468
East Asian (EAS)
AF:
0.0518
AC:
268
AN:
5178
South Asian (SAS)
AF:
0.347
AC:
1672
AN:
4820
European-Finnish (FIN)
AF:
0.283
AC:
2989
AN:
10578
Middle Eastern (MID)
AF:
0.265
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
0.216
AC:
14668
AN:
67986
Other (OTH)
AF:
0.210
AC:
444
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1205
2411
3616
4822
6027
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.208
Hom.:
8533
Bravo
AF:
0.178
TwinsUK
AF:
0.204
AC:
758
ALSPAC
AF:
0.192
AC:
739
ESP6500AA
AF:
0.135
AC:
596
ESP6500EA
AF:
0.217
AC:
1864
ExAC
AF:
0.218
AC:
26450
Asia WGS
AF:
0.180
AC:
628
AN:
3478
EpiCase
AF:
0.219
EpiControl
AF:
0.218

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 29, 2012
Claritas Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Nov 15, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

COFS syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cockayne syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Macular degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
2.1
DANN
Benign
0.62
DEOGEN2
Benign
0.081
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.31
T
MetaRNN
Benign
0.0035
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L
PhyloP100
0.10
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.16
Sift
Benign
0.51
T
Sift4G
Benign
0.49
T
Polyphen
0.13
B
Vest4
0.034
MPC
0.12
ClinPred
0.0011
T
GERP RS
-4.9
Varity_R
0.023
gMVP
0.23
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228529; hg19: chr10-50667105; COSMIC: COSV63389074; COSMIC: COSV63389074; API